Penn’s one-stop solution for technology commercialization and entrepreneurship
I’m a Faculty Member or Researcher
I’m with a Company
I’m an Entrepreneur
I want to:
Translating Discoveries
PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
PCI’s New Technology LinkedIn Page
PCI recently launched a new LinkedIn page showcasing our technologies that are currently available for investment and partnership opportunities. Follow here.
Penn Startups Raising Capital in 2025
Learn about which Penn startup companies are raising capital in 2025 with this comprehensive list. With companies in connected health, digital health, diagnostics, therapeutics, and medical devices, Penn offers a wide range of rapidly emerging companies at all investment levels.
If you are interested in connecting about these startups, please email Laurie Actman (lactman@upenn.edu).
Download and view the complete listAvailable Technologies
Find technology opportunities by sector or search:
Nanotechnology | Antibody | Optics & Photonics | Medical Devices | COVID-19 | Immunology | Oncology | Materials | Bioengineering | Neurodegenerative Diseases
View all technologies
Recent News
All NewsNew Mini-documentary Showcases the Path to CAR-T Cell Therapy
Penn Engineering Faculty Attend AI & Energy Summit in Pittsburgh
Penn Health-Tech’s Katie Reuther Publishes Life Sciences Pitch Deck Guide in Nature Biotechnology
David Meaney Named Vice Provost for Research and Mark Dingfield Named Executive Vice President at Penn | Penn Today
Read the PCI FY24 Year in Review
1500
Active Commercial Partnership Agreements
150+
Active Penn Spinouts (152)
125
Issued U.S. Patents (+20% from FY23)
#13
Nationally for Utility Patents (NAI Worldwide Universities Granted US Utility Patents)
Discover CAR T-cell technology at Penn
Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.